These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 6110314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Longterm therapy of schizophrenia].
    Pajonk FG, Wobrock T, Falkai P.
    Fortschr Neurol Psychiatr; 2005 Mar; 73(3):161-74; quiz 175-7. PubMed ID: 15747226
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Depot neuroleptics in social psychiatric practice].
    Pruss U, Rose HK, Zechner A.
    Psychiatr Prax; 1984 Jul; 11(4):101-8. PubMed ID: 6148764
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of acute and chronic psychoses in childhood and adolescence].
    Eggers Ch.
    MMW Fortschr Med; 2005 Dec 01; 147(48):41, 43-5. PubMed ID: 16389861
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Modification of long-term schizophrenia by somato-therapeutic measures].
    Gross G, Huber G, Schüttler R.
    Psychiatr Clin (Basel); 1980 Dec 01; 13(3-4):179-92. PubMed ID: 6113621
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Is depot formulation a long-term optimal treatment option?].
    Musch A.
    Med Monatsschr Pharm; 2005 Nov 01; 28(11):414-6. PubMed ID: 16309031
    [No Abstract] [Full Text] [Related]

  • 11. [Long-term therapy with depot neuroleptics. Prevention of recurrence in chronic schizophrenic patients].
    Bergener M, Husser J, Kranzhoff EU, Charap A.
    Fortschr Med; 1986 Oct 23; 104(40):756-60. PubMed ID: 2877927
    [No Abstract] [Full Text] [Related]

  • 12. The attitude of patients towards antipsychotic depot treatment.
    Heres S, Schmitz FS, Leucht S, Pajonk FG.
    Int Clin Psychopharmacol; 2007 Sep 23; 22(5):275-82. PubMed ID: 17690596
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Changes in the symptomatological picture of schizophrenia in relation to the introduction of neuroleptics].
    Modrzewska K.
    Psychiatr Pol; 1988 Sep 23; 22(5):349-55. PubMed ID: 2907659
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone.
    Martin SD, Libretto SE, Pratt DJ, Brewin JS, Huq ZU, Saleh BT.
    Curr Med Res Opin; 2003 Sep 23; 19(4):298-305. PubMed ID: 12841922
    [Abstract] [Full Text] [Related]

  • 17. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
    Gutwinski S, Müller P, Koller M.
    Psychiatr Prax; 2007 Sep 23; 34(6):289-91. PubMed ID: 17806015
    [Abstract] [Full Text] [Related]

  • 18. [Effects of depot neuroleptics on pituitary hormone secretion (author's transl)].
    Czernik A, Kleesiek K.
    Nervenarzt; 1979 Aug 23; 50(8):527-33. PubMed ID: 43482
    [No Abstract] [Full Text] [Related]

  • 19. Older people with chronic schizophrenia.
    Karim S, Overshott R, Burns A.
    Aging Ment Health; 2005 Jul 23; 9(4):315-24. PubMed ID: 16019287
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.